Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects a small page update and does not modify the study data or how the page functions.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page shows a new revision tag (v3.5.4) replacing the prior version, signaling a minor site update without altering study information.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting an incremental update to the site itself rather than the underlying clinical trial information.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page layout are indicated.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.0 replaced v3.4.3 in the page header/footer. No observed changes to the study details, eligibility criteria, or navigation.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.